Multiple Myeloma Therapy Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Multiple Myeloma Therapy Market in 2025 is evaluated at USD 22.68 billion. The global market size was worth around USD 21.74 billion in 2024 and is set to register a CAGR of more than 5.4%, exceeding USD 43.07 billion revenue by 2037. Asia Pacific is projected to obtain USD 10.77 billion by 2037, attributed to increased government funding in cancer R&D.
In addition, the number of diagnoses is increasing. The manufacturers are designing and developing new products and drugs for the treatment of multiple myeloma. These factors are bolstering the market growth of multiple myeloma market. Also, the advancement in therapies and drugs is growing owing to the reports indicating an increase in the incidence of multiple myeloma around the world. According to data from 2015 to 2019, 7.1 persons will receive a myeloma diagnosis per 100,000 people each year. It will cause about 3.2 out of 100,000 deaths.
